Integrin Activation Enables Sensitive Detection of Functional CD4+ and CD8+ T Cells: Application to Characterize

Anna Schöllhorn1, Juliane Schuhmacher1, Luciana Besedovsky2

  • 1Department of Immunology, Institute for Cell Biology, University of Tübingen, Tübingen, Germany.

Insights

This study introduces a new assay to detect functional antigen-specific CD4+ and CD8+ T cells. The method uses a modified beta-2 integrin activation marker for sensitive screening in infectious disease and vaccination research.

Area of Science:

  • Immunology
  • Cellular Biology
  • Virology

Background:

  • Beta-2 integrin conformational change is an early activation marker for antigen-specific CD8+ T cells.
  • Previous methods allowed rapid assessment of CD8+ T cell responses.

Purpose of the Study:

  • To develop a modified assay for sensitive detection of functional antigen-specific CD4+ T cells.
  • To enable simultaneous screening of both CD4+ and CD8+ T cell reactivities.

Main Methods:

  • Utilized a modified protocol employing a monoclonal antibody (m24 Ab) targeting the high-affinity conformation of beta-2 integrin.
  • Assessed T cell responses in whole blood or PBMCs from individuals infected/vaccinated with SARS-CoV-2, CMV, EBV, and HBV.
  • Employed co-staining with m24 and CD154 antibodies to evaluate polyfunctional CD4+ T cell responses.

Main Results:

  • The modified assay effectively detects functional antigen-specific CD4+ T cells.
  • Beta-2 integrin activation kinetics differ between CD4+ and CD8+ T cells, but m24 Ab stains both 4-6 hours post-stimulation.
  • The assay successfully monitored T cell responses to SARS-CoV-2, CMV, EBV, and HBV.
  • Detected extremely low frequencies of polyfunctional CD4+ T cell responses.

Conclusions:

  • A novel, sensitive assay allows simultaneous screening of CD4+ and CD8+ T cell reactivities.
  • The assay is versatile for clinical and vaccination studies, enabling monitoring of effector and memory T cells.
  • This method enhances the assessment of T cell immunity against various viral infections.